Cargando...

Generation and characterization of aptamers targeting factor XIa

BACKGROUND: The plasma protease factor XIa (FXIa) has become a target of interest for therapeutics designed to prevent or treat thrombotic disorders. METHODS: We used a solution-based, directed evolution approach called systematic evolution of ligands by exponential enrichment (SELEX) to isolate RNA...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Thromb Res
Main Authors: Woodruff, R. S., Ivanov, I., Verhamme, I.M., Sun, M-f., Gailani, D., Sullenger, B.A
Formato: Artigo
Idioma:Inglês
Publicado: 2017
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5697752/
https://ncbi.nlm.nih.gov/pubmed/28644959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.thromres.2017.06.015
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!